Clearmind Medici Financials
This page shows Clearmind Medici (CMND) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 5 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
Clearmind Medici does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.
Clearmind Medici passes 1 of 5 computable financial strength tests (4 of the nine could not be computed from available data). 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution).
Clearmind Medici reported a net loss of $3.9M while operations used $4.7M of cash. With neither figure positive, the ratio between the two carries no quality signal.
Key Financial Metrics
Earnings & Revenue
Clearmind Medici reported -$3.9M in net income in fiscal year 2025. This represents an increase of 26.6% from the prior year.
Not reported for fiscal year 2025.
Not reported for fiscal year 2025.
Not reported for fiscal year 2025.
Cash & Balance Sheet
Clearmind Medici held $3.9M in cash as of fiscal year 2025; long-term debt is not reported for that period.
Not reported for fiscal year 2025.
Not reported for fiscal year 2025.
Margins & Returns
Clearmind Medici's ROE was -323.4% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 154.3 percentage points from the prior year.
Not reported for fiscal year 2025.
Not reported for fiscal year 2025.
Not reported for fiscal year 2025.
Capital Allocation
None of these metrics is reported for fiscal year 2025.
CMND Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | TTM | FY25 | FY24 | FY23 | FY22 | FY21 |
|---|---|---|---|---|---|---|
| Interest Expense | N/A | $4K-28.4% | $5K+85.3% | $3K-79.9% | $14K+158.8% | -$25K |
| Income Tax | N/A | $70K-81.4% | $378K+2075.7% | $17K-41.8% | $30K | N/A |
| Net Income | N/A | -$3.9M+26.6% | -$5.3M+39.0% | -$8.6M | N/A | -$2.7M |
Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, Operating Income, EPS (Diluted).
TTM is the trailing twelve months, Q2 FY2025 through Q1 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.
CMND Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | FY25 | FY24 | FY23 | FY22 | FY21 |
|---|---|---|---|---|---|
| Total Assets | $6.1M-16.2% | $7.3M+21.9% | $6.0M+620.4% | $826K | N/A |
| Current Assets | $5.9M-16.1% | $7.1M+22.3% | $5.8M+1233.0% | $435K | N/A |
| Cash & Equivalents | $3.9M-40.3% | $6.6M+21.1% | $5.4M+4114.8% | $129K-96.2% | $3.4M |
| Accounts Receivable | N/A | N/A | N/A | $51K | N/A |
| Total Liabilities | $4.9M+17.9% | $4.1M-16.5% | $5.0M+157.2% | $1.9M | N/A |
| Current Liabilities | $4.9M+18.4% | $4.1M-16.9% | $5.0M | N/A | N/A |
| Long-Term Debt | N/A | $16K | N/A | N/A | N/A |
| Total Equity | $1.2M-61.6% | $3.1M+216.0% | $983K+188.9% | -$1.1M-131.4% | $3.5M |
| Retained Earnings | -$27.9M-16.1% | -$24.0M-28.0% | -$18.8M-85.0% | -$10.1M | N/A |
Not reported in any period shown, so not listed: Inventory, Goodwill.
CMND Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | TTM | FY25 | FY24 | FY23 | FY22 | FY21 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -$5.6M | -$4.7M+2.6% | -$4.9M+22.9% | -$6.3M-69.2% | -$3.7M-79.3% | -$2.1M |
| Capital Expenditures | N/A | N/A | N/A | N/A | $6K-67.2% | $17K |
| Free Cash Flow | N/A | N/A | N/A | N/A | -$3.7M-78.1% | -$2.1M |
| Investing Cash Flow | N/A | -$542K-127.6% | -$238K-807.8% | -$26K-371.5% | -$6K+97.0% | -$184K |
| Financing Cash Flow | $9.6M | $2.6M-58.1% | $6.3M-46.4% | $11.7M+2179.6% | $512K-90.5% | $5.4M |
Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.
TTM is the trailing twelve months, Q2 FY2025 through Q1 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.
CMND Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples.
| Metric | FY25 | FY24 | FY23 | FY22 | FY21 |
|---|---|---|---|---|---|
| Return on Equity | -323.4%-154.3pp | -169.1%+707.5pp | -876.6% | N/A | -77.5% |
| Return on Assets | -63.4%+9.0pp | -72.4%+72.4pp | -144.8% | N/A | N/A |
| Current Ratio | 1.22-0.5x | 1.72+0.5x | 1.17 | N/A | N/A |
| Debt-to-Equity | 4.10+4.1x | 0.01-5.0x | 5.05 | N/A | N/A |
Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, FCF Margin.
Similar Companies
Where Clearmind Medici Ranks
Frequently Asked Questions
Is Clearmind Medici profitable?
No, Clearmind Medici (CMND) reported a net income of -$3.9M in fiscal year 2025.
What is Clearmind Medici's return on equity (ROE)?
Clearmind Medici (CMND) has a return on equity of -323.4% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Clearmind Medici's operating cash flow?
Clearmind Medici (CMND) recorded an outflow of $4.7M in operating cash flow during fiscal year 2025, representing cash used by core business activities.
What are Clearmind Medici's total assets?
Clearmind Medici (CMND) had $6.1M in total assets as of fiscal year 2025, including both current and long-term assets.
What is Clearmind Medici's current ratio?
Clearmind Medici (CMND) had a current ratio of 1.22 as of fiscal year 2025, which is considered adequate.
What is Clearmind Medici's debt-to-equity ratio?
Clearmind Medici (CMND) had a debt-to-equity ratio of 4.10 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Clearmind Medici's return on assets (ROA)?
Clearmind Medici (CMND) had a return on assets of -63.4% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Clearmind Medici's cash runway?
Based on fiscal year 2025 data, Clearmind Medici (CMND) had $3.9M in cash against an annual operating cash burn of $4.7M. This gives an estimated cash runway of approximately 10 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.
What is Clearmind Medici's Piotroski F-Score?
Clearmind Medici (CMND) has a Piotroski F-Score of 1 out of 5 computable signals; 4 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Clearmind Medici's earnings high quality?
Clearmind Medici (CMND) reported a net loss of $3.9M while operations used $4.7M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.